A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Rimexolone
Gilteritinib
The metabolism of Gilteritinib can be increased when combined with Colchicine.
Rimexolone
Duvelisib
The metabolism of Duvelisib can be increased when combined with Colchicine.
Rimexolone
Dihydroergocornine
The metabolism of Dihydroergocornine can be increased when combined with Colchicine.
Rimexolone
Vitamin D
The metabolism of Vitamin D can be increased when combined with Colchicine.
Rimexolone
Tenofovir alafenamide
The metabolism of Tenofovir alafenamide can be increased when combined with Colchicine.
Rimexolone
Nintedanib
The metabolism of Nintedanib can be increased when combined with Colchicine.
Rimexolone
Tasimelteon
The metabolism of Tasimelteon can be increased when combined with Colchicine.
Rimexolone
Lacosamide
The metabolism of Lacosamide can be increased when combined with Colchicine.
Rimexolone
Rufinamide
The metabolism of Rufinamide can be increased when combined with Colchicine.
Rimexolone
Zuclopenthixol
The metabolism of Zuclopenthixol can be increased when combined with Colchicine.
Rimexolone
Allylestrenol
The metabolism of Allylestrenol can be increased when combined with Colchicine.
Rimexolone
Pranlukast
The metabolism of Pranlukast can be increased when combined with Colchicine.
Rimexolone
Isotretinoin
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Isotretinoin is combined with Colchicine.
Rimexolone
Triazolam
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Colchicine.
Rimexolone
Ubidecarenone
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Colchicine is combined with Ubidecarenone.
Rimexolone
Ipecac
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Colchicine is combined with Ipecac.
Rimexolone
Fenofibric acid
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Colchicine is combined with Fenofibric acid.
Rimexolone
Clofibride
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Colchicine is combined with Clofibride.
Rimexolone
Aluminium clofibrate
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Colchicine is combined with Aluminium clofibrate.
Rimexolone
Ronifibrate
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Colchicine is combined with Ronifibrate.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3